Loading…
BVI completed the acquisition of Benz Research & Development and its subsidiary SpecialEyes, both based in Sarasota, Florida. Benz supplies performance materials and manufacturing technology for intraocular lenses (IOLs).
BVI acquired the ophthalmic viscoelastic device (OVD) assets from Croma Pharma GmbH of Austria and launched NuVisc PRO in Europe. The companies also entered an R&D collaboration for additional products.